DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Motzer RJ, Escudier B, Oudard S, Porta C, Hutson TE, Bracarda S, Hollaender N, Urbanowitz G, Kay A, Ravaud A.
RAD001 vs placebo in patients with metastatic renal cell
carcinoma (RCC) after progression on VEGFr-TKI therapy: Results from a
randomized, double-blind, multicenter Phase-III study.
J Clin Oncol 2008; 26
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.